Rivastigmine Film, Extended Release
Mylan Pharmaceuticals Inc., a Viatris Company
Open FDA's page for this record- Discontinued date
- 09/18/2026
- Update type
- New
- Initial posting date
- 09/18/2026
- Package NDC
- 0378-9070-93
- Generic name
- Rivastigmine Film, Extended Release
- Contact info
- 800-796-9526
- Related info
- Discontinuation of the manufacture of the drug.
- Update date
- 09/18/2026
- Dosage form
- Film, Extended Release
- Presentation
- Rivastigmine, Film, Extended Release, 4.6 mg/24 h (NDC 0378-9070-93)
- Company name
- Mylan Pharmaceuticals Inc., a Viatris Company
- Status
- To Be Discontinued
- Therapeutic category
- Neurology
- Harmonized identifiers (openFDA)
- Application number
- ANDA205622
- Brand name
- RIVASTIGMINE
- Generic name
- RIVASTIGMINE
- Manufacturer name
- Mylan Pharmaceuticals Inc.
- Product NDC
- 0378-9070, 0378-9071, 0378-9072
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- TRANSDERMAL
- Substance name
- RIVASTIGMINE
- RxCUI
- 725021, 725023, 1308569
- SPL ID
- c1d8c8a9-87e9-4ca1-ba70-4a7467205fd4
- SPL set ID
- 4ab335d1-19ee-4cd9-9776-8086645d19e4
- Package NDC
- 0378-9070-16, 0378-9070-93, 0378-9071-16, 0378-9071-93, 0378-9072-16, 0378-9072-93
- Nui
- N0000175723, N0000000177
- Pharm class epc
- Cholinesterase Inhibitor [EPC]
- Pharm class moa
- Cholinesterase Inhibitors [MoA]
- UNII
- PKI06M3IW0
